Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2026)
Ginkgo Bioworks Holdings posted quarterly Change in Acquisitions & Divestments of $108.2 million for Q1 2026, down 32.17% on a QoQ basis from $159.5 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $108.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $108.2 million; the trailing twelve-month figure through Mar 2026 stood at $267.7 million (changed N/A YoY), and the FY2025 full-year result was $159.5 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $108.2 million, down from $159.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $159.5 million in Q4 2025 and bottomed at -$65.0 million in Q3 2025.
- The 3-year median for Change in Acquisitions & Divestments is $32.5 million (2022), against an average of $44.6 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 41.41% in 2022, while the deepest fall reached 129.13% in 2022.
- A 3-year view of Change in Acquisitions & Divestments shows it stood at -$30000.0 in 2022, then soared by 531710.0% to $159.5 million in 2025, then sank by 32.17% to $108.2 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $108.2 million (Q1 2026), $159.5 million (Q4 2025), and -$65.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.18 Mn |
| Mar 31, 2026 | 108.18 Mn |
| Dec 31, 2025 | 159.48 Mn |
| Dec 31, 2025 | 159.48 Mn |
| Sep 30, 2025 | -64.96 Mn |
| Sep 30, 2025 | -64.96 Mn |
| Jun 30, 2025 | 64.96 Mn |
| Jun 30, 2025 | 64.96 Mn |
| Jun 30, 2022 | -30,000.00 |
| Jun 30, 2022 | -30,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Mar 31, 2021 | 99,000.00 |